Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets von Moreira, A., Masliah-Planchon, J., Callens, C., Vacher, S., Lecerf, C., Frelaut, M., Borcoman, E., Torossian, N., Ricci, F., Hescot, S., Sablin, M.P., Tresca, P., Loirat, D., Melaabi, S., Trabelsi-Grati, O., Pierron, G., Gentien, D., Bernard, V., Vincent Salomon, A., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells von Tran Quang, C, Leboucher, S, Passaro, D, Fuhrmann, L, Nourieh, M, Vincent-Salomon, A, Ghysdael, J

Volltext

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay von Mouttet, D, Laé, M, Caly, M, Gentien, D, Carpentier, S, Peyro-Saint-Paul, H, Vincent-Salomon, A, Rouzier, R, Sigal-Zafrani, B, Sastre-Garau, X, Reyal, F

Volltext

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers von Coussy, F, El Botty, R, Lavigne, M, Gu, C, Fuhrmann, L, Briaux, A, de Koning, L, Dahmani, A, Montaudon, E, Morisset, L, Huguet, L, Sourd, L, Painsec, P, Chateau-Joubert, S, Larcher, T, Vacher, S, Melaabi, S, Salomon, A Vincent, Marangoni, E, Bieche, I

Volltext

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma von Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F

Volltext

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer von Faucheux, L., Grandclaudon, M., Perrot-Dockès, M., Sirven, P., Berger, F., Hamy, A.S., Fourchotte, V., Vincent-Salomon, A., Mechta-Grigoriou, F., Reyal, F., Scholer-Dahirel, A., Guillot-Delost, M., Soumelis, V.

Volltext

Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts von Cottu, P., Marangoni, E., Assayag, F., de Cremoux, P., Vincent-Salomon, A., Guyader, Ch, de Plater, L., Elbaz, C., Karboul, N., Fontaine, J. J., Chateau-Joubert, S., Boudou-Rouquette, P., Alran, S., Dangles-Marie, V., Gentien, D., Poupon, M.-F., Decaudin, D.

Volltext

Complex cystic breast masses in ultrasound examination von Athanasiou, A, Aubert, E, Vincent Salomon, A, Tardivon, A

Volltext

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy von Park, J H, Jonas, S F, Bataillon, G, Criscitiello, C, Salgado, R, Loi, S, Viale, G, Lee, H J, Dieci, M V, Kim, S -B, Vincent-Salomon, A, Curigliano, G, André, F, Michiels, S

Volltext

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer von Cottu, P.H., Asselah, J., Lae, M., Pierga, J.-Y., Diéras, V., Mignot, L., Sigal-Zafrani, B., Vincent-Salomon, A.

Volltext

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer von Tarantino, P., Viale, G., Press, M.F., Hu, X., Penault-Llorca, F., Bardia, A., Batistatou, A., Burstein, H.J., Carey, L.A., Cortes, J., Denkert, C., Diéras, V., Jacot, W., Koutras, A.K., Lebeau, A., Loibl, S., Modi, S., Mosele, M.F., Provenzano, E., Pruneri, G., Reis-Filho, J.S., Rojo, F., Salgado, R., Schmid, P., Schnitt, S.J., Tolaney, S.M., Trapani, D., Vincent-Salomon, A., Wolff, A.C., Pentheroudakis, G., André, F., Curigliano, G.

Volltext

Wide metastatic spreading in infiltrating lobular carcinoma of the breast von Ferlicot, S, Vincent-Salomon, A, Médioni, J, Genin, P, Rosty, C, Sigal-Zafrani, B, Fréneaux, P, Jouve, M, Thiery, J.-P, Sastre-Garau, X

Volltext

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients von Lefort, S, Thuleau, A, Kieffer, Y, Sirven, P, Bieche, I, Marangoni, E, Vincent-Salomon, A, Mechta-Grigoriou, F

Volltext

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants von Villy, M.-C., Masliah-Planchon, J., Melaabi, S., Trabelsi Grati, O., Girard, E., Bataillon, G., Vincent-Salomon, A., Le Gall, J., Golmard, L., Stoppa-Lyonnet, D., Bieche, I., Colas, C.

Volltext

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer von Van Baelen, K, Geukens, T, Maetens, M, Tjan-Heijnen, V, Lord, C J, Linn, S, Bidard, F-C, Richard, F, Yang, W W, Steele, R E, Pettitt, S J, Van Ongeval, C, De Schepper, M, Isnaldi, E, Nevelsteen, I, Smeets, A, Punie, K, Voorwerk, L, Wildiers, H, Floris, G, Vincent-Salomon, A, Derksen, P W B, Neven, P, Senkus, E, Sawyer, E, Kok, M, Desmedt, C

Volltext

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer von Cottu, P., D'Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P.-E., Duhoux, F.P., Levy, C., Mouret-Reynier, M.-A., Dalenc, F., Frenel, J.-S., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J.-M., Canon, J.-L., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., Delaloge, S.

Volltext

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer von Hamy, A.-S., Pierga, J.-Y., Sabaila, A., Laas, E., Bonsang-Kitzis, H., Laurent, C., Vincent-Salomon, A., Cottu, P., Lerebours, F., Rouzier, R., Lae, M., Reyal, F.

Volltext

p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer von Lodillinsky, C, Infante, E, Guichard, A, Chaligné, R, Fuhrmann, L, Cyrta, J, Irondelle, M, Lagoutte, E, Vacher, S, Bonsang-Kitzis, H, Glukhova, M, Reyal, F, Bièche, I, Vincent-Salomon, A, Chavrier, P

Volltext

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: the pathologists' perspective von Salgado, R., Peg, V., Rüschoff, J., Vincent-Salomon, A., Castellano, I., Perner, S., Van de Vijver, K., Quinn, C.M., Varga, Z.

Volltext

Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions von MacGrogan, G, Arnould, L, De Mascarel, I, Vincent-Salomon, A, Penault-Llorca, F, Lacroix-Triki, M, Bibeau, F, Baranzelli, M C, Fridman, V, Antoine, M, Bécette, V, Brouste, V, Jacquemier, J, Mathoulin-Pélissier, S

Volltext